Antihistamine Therapy for Allergic Reactions

Introduction to Antihistamine Selection

The American Academy of Allergy, Asthma, and Immunology recommends fexofenadine 120-180 mg once daily as the first-line choice for most patients with allergic reactions due to its non-sedating properties, rapid onset, and 24-hour efficacy 1
No single second-generation antihistamine has been conclusively shown to have superior overall efficacy for allergic rhinitis symptoms, with all four agents (fexofenadine, loratadine, levocetirizine, and desloratadine) effectively reducing symptoms 1, 2

Fexofenadine causes zero sedation even at doses up to 240 mg/day because it does not cross the blood-brain barrier, making it a preferred option for patients requiring alertness 1
Loratadine does not cause sedation at recommended doses (10 mg), but may cause sedation at higher-than-recommended levels 1, 2
Levocetirizine (and cetirizine) cause mild drowsiness in 13.7% of patients versus 6.3% with placebo, making them less suitable for patients requiring alertness 2

For school-aged children, fexofenadine is the first choice due to its non-sedating properties, which won't affect school performance 1
For elderly patients, fexofenadine or loratadine are preferred due to their lower sedative potential and reduced fall risk 1, 2
For patients with renal impairment, levocetirizine/cetirizine require dose adjustment, and loratadine should be used with caution 2

If a patient requires rapid symptom relief within 2 hours, fexofenadine 120-180 mg is recommended 1
If a patient fails standard therapy with loratadine or fexofenadine, switching to levocetirizine 5 mg once daily may be considered, accepting the sedation risk 2

All antihistamines have limited effect on nasal congestion, and adding pseudoephedrine or using intranasal corticosteroids may be necessary 1, 3
First-generation antihistamines (diphenhydramine, chlorpheniramine) should not be used as first-line therapy due to significant sedation and cognitive impairment 1
Antihistamines should not be used as first-line treatment for asthma, as they have modest effects on asthma symptoms but do not improve pulmonary function tests 3